Search research articles
Contact Us
Filters
Showing results (121-130 of 184) with videos related to
Page
of 19
Sort By:
Cancers
|
December 30, 2025
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Garima Gupta, Negar Sadeghipour, Fuat Bicer, et al.
Journal of Neuro-Oncology
|
October 15, 2011
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients
David A Reardon, James E Herndon, Katherine Peters, et al.
BMJ Oncology
|
April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
Sepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC
Vaia Florou, Andrew Elliott, Matthew H Bailey, et al.
Cell Reports. Medicine
|
April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes
Yuting Shan, Yingbo Huang, Adam Lee, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Cancer Gene Therapy
|
August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Cytotherapy
|
July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers
Matthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 184) with videos related to
Sort By:
Page
of 19
Cancers
|
December 30, 2025
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors
Garima Gupta, Negar Sadeghipour, Fuat Bicer, et al.
Journal of Neuro-Oncology
|
October 15, 2011
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients
David A Reardon, James E Herndon, Katherine Peters, et al.
BMJ Oncology
|
April 8, 2026
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
Sepideh Gholami, Anwaar Saeed, Yasmine Baca, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC
Vaia Florou, Andrew Elliott, Matthew H Bailey, et al.
Cell Reports. Medicine
|
April 21, 2026
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes
Yuting Shan, Yingbo Huang, Adam Lee, et al.
Molecular Therapy. Oncology
|
April 10, 2024
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
Emil Lou, Joanne Xiu, Yasmine Baca, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Cancer Gene Therapy
|
August 22, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshmukh, Sharon Wu, et al.
Cytotherapy
|
July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers
Matthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Page
of 19